A drug that receives Fast Track designation may benefit from more frequent interactions with the FDA throughout drug development. In addition, the Fast Track program allows for Accelerated Approval ...

The NPI-001 (N-acetylcysteine amide) tablets are a proprietary investigational therapy for the treatment of patients with ...

retinitis pigmentosa, glaucoma, or other conditions that affect vision. It may also arise after cataract surgery or after a stroke. Charles Bonnet syndrome is not due to dementia, psychosis ...

In retinitis pigmentosa, the rods and cones in the photoreceptors ... extensive compared to other eye procedures like ...